Bank of America
NVAX icon

Bank of America’s Novavax NVAX Stock Holding History

Bank of America’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-200,000
Closed -$2.53M – 8336
2024
Q3 		$2.53M Sell
200,000
-3,200
-2% -$41.3K ﹤0.01% 4380
2024
Q2 		$2.57M Sell
203,200
-372,100
-65% -$3.74M ﹤0.01% 4234
2024
Q1 		$2.75M Sell
575,300
-987,100
-63% -$4.58M ﹤0.01% 4193
2023
Q4 		$7.5M Buy
1,562,400
+675,600
+76% +$4.14M ﹤0.01% 3194
2023
Q3 		$6.42M Buy
886,800
+251,300
+40% +$2.01M ﹤0.01% 3168
2023
Q2 		$4.72M Buy
635,500
+260,800
+70% +$2.05M ﹤0.01% 3463
2023
Q1 		$2.6M Sell
374,700
-329,300
-47% -$3.03M ﹤0.01% 4113
2022
Q4 		$7.24M Buy
704,000
+418,900
+147% +$7.39M ﹤0.01% 3003
2022
Q3 		$5.19M Buy
285,100
+107,400
+60% +$4.65M ﹤0.01% 3312
2022
Q2 		$9.14M Buy
177,700
+102,700
+137% +$5.32M ﹤0.01% 2788
2022
Q1 		$5.52M Sell
75,000
-96,900
-56% -$8.64M ﹤0.01% 3512
2021
Q4 		$24.6M Buy
171,900
+163,800
+2,022% +$28.1M ﹤0.01% 2021
2021
Q3 		$1.68M Sell
8,100
-58,400
-88% -$12.9M ﹤0.01% 4603
2021
Q2 		$14.1M Buy
+66,500
New +$12.2M ﹤0.01% 2472
2019
Q1 		– Sell
-500
Closed -$18K – 7320
2018
Q4 		$18K Buy
+500
New +$19.4K ﹤0.01% 6506
2015
Q1 		– Sell
-360
Closed -$43K – 7402
2014
Q4 		$43K Sell
360
-530
-60% -$55.4K ﹤0.01% 6423
2014
Q3 		$74K Sell
890
-160
-15% -$14.5K ﹤0.01% 6238
2014
Q2 		$97K Sell
1,050
-180
-15% -$15.8K ﹤0.01% 6171
2014
Q1 		$111K Buy
+1,230
New +$137K ﹤0.01% 5915

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America's NVAX Position: Q1 2026 in Review

Bank of America reduced its Novavax (NVAX) stake by 20% in Q1 2026, selling an estimated $15M and leaving 6,637,213 shares worth $54M. The position accounts for ﹤0.01% of the portfolio, ranked #1535.

Bank of America first reported a position in NVAX in Q2 2013 and has held it in 52 quarters since. The position peaked at $55.7M in Q4 2025. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Bank of America held 6,637,213 shares of Novavax worth $54M as of Q1 2026.
  • Bank of America sold 1,653,452 Novavax shares in Q1 2026, an estimated $15M.
  • Novavax made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1535 holding.
  • Bank of America first reported a position in Novavax in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Novavax position peaked at $55.7M in Q4 2025.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.